Rancho Santa Fe, CA, United States of America

Jason M Cox

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignees: Merck Sharp & Dohme LLC, Celyn Therapeutics, Inc, Khora Spv 1, LLC. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason M Cox. Retrieved from https://idiyas.com/inventor/jason-m-cox-9gk4avzo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.8

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jason M. Cox: Innovator in Fibroblast Growth Factor Receptor Kinase Inhibitors

Introduction

Jason M. Cox is a notable inventor based in Rancho Santa Fe, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for fibroblast growth factor receptor kinases. His work is crucial for advancing treatments for various diseases.

Latest Patents

Jason holds a patent for "Inhibitors of fibroblast growth factor receptor kinases." This patent includes heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising these compounds, and methods for using them in the treatment of diseases. He has 1 patent to his name, showcasing his innovative approach to medical science.

Career Highlights

Jason is currently associated with Khora SPV 1, LLC, where he continues to work on groundbreaking research and development in the pharmaceutical industry. His expertise in kinase inhibitors positions him as a valuable asset in the field.

Collaborations

Throughout his career, Jason has collaborated with esteemed colleagues such as Stephen W. Kaldor and John Tyhonas. These partnerships have further enhanced his research and contributed to the advancement of their shared goals in medical innovation.

Conclusion

Jason M. Cox exemplifies the spirit of innovation in the pharmaceutical industry through his work on fibroblast growth factor receptor kinase inhibitors. His contributions are paving the way for new treatments and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…